Viral Exposure Signature Associated with Liver Cancer Risk.


Journal

Trends in molecular medicine
ISSN: 1471-499X
Titre abrégé: Trends Mol Med
Pays: England
ID NLM: 100966035

Informations de publication

Date de publication:
08 2020
Historique:
received: 28 06 2020
accepted: 29 06 2020
pubmed: 14 7 2020
medline: 8 7 2021
entrez: 14 7 2020
Statut: ppublish

Résumé

Virus infection is known to increase the risk of various cancers, including hepatocellular carcinoma (HCC). In a recent article in Cell, Liu et al. report a blood-based viral exposure signature (VES) based on a synthetic human virome to capture the history of virus exposure that is associated with future HCC occurrence.

Identifiants

pubmed: 32654969
pii: S1471-4914(20)30159-3
doi: 10.1016/j.molmed.2020.06.008
pmc: PMC9037676
mid: NIHMS1798099
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

711-713

Subventions

Organisme : European Research Council
ID : 671231
Pays : International
Organisme : NCI NIH HHS
ID : R01 CA233794
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK099558
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA226052
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Références

Nat Genet. 2015 Oct;47(10):1187-93
pubmed: 26301494
Lancet Glob Health. 2016 Sep;4(9):e609-16
pubmed: 27470177
World J Gastroenterol. 2001 Aug;7(4):445-54
pubmed: 11819809
Nat Rev Gastroenterol Hepatol. 2019 Oct;16(10):589-604
pubmed: 31439937
Cell. 2020 Jul 23;182(2):317-328.e10
pubmed: 32526205
Hepatol Res. 2020 Jul;50(7):817-830
pubmed: 32323426
Lancet. 2019 Aug 10;394(10197):497-509
pubmed: 31255301
Hepatology. 2021 Feb;73(2):713-725
pubmed: 32383272
J Hepatol. 2018 Mar;68(3):526-549
pubmed: 28989095
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593

Auteurs

Naoto Fujiwara (N)

Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Gastroenterology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

Yujin Hoshida (Y)

Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, Division of Digestive and Liver Diseases, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. Electronic address: Yujin.Hoshida@UTSouthwestern.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH